I have no idea if its related to the IHL trial, but two other trials using the same drug as IHL, one in the USA and another in France, have been delayed to allow greater research into why a small trial in Brazil needed to be stopped.
“Hydroxychloroquine, which is available as a generic drug and is also produced under the brand name Plaquenil by French drugmaker Sanofi, can have serious side effects, including muscle weakness and heart arrhythmia. A small study in Brazil was halted for safety reasons after coronavirus patients taking chloroquine, which hydroxychloroquine is derived from, developed arrhythmia, including some who died.”
The FDA have put out an update re the drugs use, highlighting the side effects.
- Forums
- ASX - By Stock
- IHL
- General discussion
General discussion, page-321
-
- There are more pages in this discussion • 20,090 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)